𝛼SK or Search

ENTITY

Aurobindo Pharma (ARBP IN)

160

Analysis

Health Care • India

Aurobindo Pharma is an Indian multinational pharmaceutical manufacturing company that develops, manufactures, and commercializes a wide range of generic pharmaceuticals, active pharmaceutical ingredients (APIs), and specialty formulations. The company's product portfolio covers therapeutic areas including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergics, oncology, and dermatology. It commenced operations in 1988-1989 with a single unit manufacturing semi-synthetic penicillin in Puducherry. Headquartered in Hyderabad, Telangana, India, the company was founded in 1986.

more

Refresh

Exchange Announcement • 18 Jul 2024 11:59

AUROBINDO PHARMA LTD. - 524804 - Intimation Of Record Date For Buyback

Exchange Announcement • 18 Jul 2024 11:51

AUROBINDO PHARMA LTD. - 524804 - Board Meeting Outcome for Outcome Of Meeting Of The Board Of Directors

Exchange Announcement • 14 Jul 2024 22:22

AUROBINDO PHARMA LTD. - 524804 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, July 18, 2024 To Consider, Inter Alia, A Proposal For Buyback Of The Fully Paid-Up Equity Shares Of The Company.

Exchange Announcement • 04 Jul 2024 15:27

AUROBINDO PHARMA LTD. - 524804 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Exchange Announcement • 28 Jun 2024 21:07

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Acquisition

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x